Sodium oxybate once-nightly (Jazz Pharmaceuticals plc)

N/A

Report date: 2024/02/28 17:56:57

Base Information

Drug NameSodium oxybate once-nightly (Jazz Pharmaceuticals plc)
Drug Alias NameExtended-release oxybate formulation (Jazz Pharmaceuticals plc)JZP-324JZP324
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsNarcolepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJazz Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesJazz Pharmaceuticals Plc
Inactive CompaniesN/A
Active IndicationsNarcolepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A